Updated:
German Capital
Dietmar Hopp's German Capital invests SAP-derived wealth across biotech, software, and real estate from Heidelberg.
German Capital
German Capital manages the private wealth of Dietmar Hopp, the co-founder of SAP SE. Hopp was among the five former IBM engineers who started the enterprise software company in 1972, which later grew into Europe's largest technology firm by market capitalization. His personal fortune, built primarily on an early SAP equity stake gradually sold down over decades, is now managed through a web of holding entities for which German Capital serves as a central Berlin-Heidelberg axis. The office deploys capital across a concentrated mix of private equity, venture capital, real estate, and public equities. An anchor of the strategy is life sciences: Dievini Hopp BioTech Holding, closely aligned with German Capital, has built and seeded a portfolio of drug-development companies, including CureVac and AC Immune. In technology, the group participates in direct venture and growth-stage deals, often with a peer-to-peer co-investment posture alongside other European family offices. The real-estate allocation includes commercial properties across the Rhine-Neckar metropolitan region. Operations are run from Heidelberg, with a Berlin presence for deal-sourcing in the startup ecosystem. Dietmar Hopp's giving — directed through the Dietmar Hopp Stiftung — sits adjacent to the family office but operates under a separate governance structure, having granted over €800 million to education, sports, and medical research since 1995. The office does not publicly disclose total assets or headcount; an Altss review of known direct holdings and fund commitments suggests a concentrated portfolio in the low billions. The structural differentiator is the office's hybrid posture: it functions simultaneously as a single-family allocator and as a philanthropic grant-maker by statute, with the closely held life-sciences platform Dievini acting as an operating-partner vehicle that blurs the line between asset manager and family office. No external capital is accepted.
General information
Firm type
Single Family Office
Year founded
—
AUM
$1B – $5B (Altss estimate)
Location
Region
Europe
Country
Germany
City
Heidelberg
Corporate office
Heidelberg, Germany
Principals
Dietmar Hopp
Principal
Sector focus
Frequently asked questions
Who runs investment decisions at German Capital?
Investment decisions flow from Dietmar Hopp as the ultimate principal. The office employs a dedicated investment team operating from Heidelberg and Berlin, with day-to-day deal execution delegated to internal professionals. No CIO or CEO is publicly named as the autonomous investment lead.
How does the firm source proprietary deal flow?
Deal flow originates from Hopp's deep network in German enterprise technology, anchored by his co-founding history at SAP, and from the office's embedded presence in the Rhine-Neckar life-sciences cluster. The office co-invests regularly with a tight circle of European family offices, which serves as a primary sourcing channel for venture and growth-stage opportunities.
What is the relationship between German Capital and Dievini Hopp BioTech Holding?
Dievini Hopp BioTech Holding is a closely held investment vehicle used as the primary platform for the life-sciences allocation within the broader Hopp family-office system. Dievini takes direct, often majority, stakes in drug-development companies and is the entity through which CureVac, AC Immune, and other portfolio companies are held. It functions as an operating investment subsidiary rather than a passive fund commitment.
Which sectors does German Capital explicitly avoid?
There is no public exclusion policy, but the observable portfolio shows no material exposure to fossil-fuel extraction, defense contracting, or tobacco. The primary negative is structural: the office avoids strategies requiring large blind-pool commitments to third-party GPs outside existing co-investment relationships.
Does German Capital participate in fund commitments or only direct deals?
The office conducts direct deals and direct co-investments as its primary mode of deployment, particularly in life sciences through Dievini. Fund commitments are used selectively for access to geographies or strategies outside the core European and US technology and healthcare verticals, but the office does not operate as a fund-of-funds allocator.
How is Dietmar Hopp's philanthropic giving structured relative to the family office?
Philanthropy flows through the Dietmar Hopp Stiftung, a legally separate foundation established in 1995. It is the primary vehicle for grant-making in youth sports, education, and medical research, with over €800 million deployed since inception. The foundation is governed independently from the investment office, though both share a common principal.
Where does the underlying wealth come from?
The wealth originates from Dietmar Hopp's role as a co-founder of SAP SE, the enterprise-software company started in 1972 in Walldorf, Germany. Hopp held a significant equity stake through SAP's 1988 public listing and subsequent growth into one of the world's largest technology companies, liquidating shares over a multi-decade period.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: